XCath, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
XCath, Inc. - overview
Established
2017
Location
Houston, TX, US
Primary Industry
Medical Devices & Equipment
About
Founded in 2017 and based in Houston, Texas, XCath operates as a medical device company developing robotic systems and steerable instruments for endovascular procedures, with its technology. Founded in 2017 and based in Houston, Texas, XCath, Inc. is led by CEO Eduardo Fonseca. In March 2026, XCath, Inc.
raised USD 30 million in series C funding co-led by Crescent Enterprises and the company's management. In March 2026, XCath, Inc. raised USD 30 million in series C funding to support further development and future commercialization of its endovascular surgical robot and advance clinical telerobotic mechanical thrombectomy efforts.
Current Investors
Crescent Enterprises
Primary Industry
Medical Devices & Equipment
Sub Industries
Surgical Devices
Website
www.xcath.com
Verticals
Robotics
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.